Ocrevus, also known as Ocrelizumab, is a medication used for the treatment of multiple sclerosis (MS). It is an immunosuppressive drug that targets It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes. It is considered a first-in-class medication and reduces the frequency of relapses by 46% and disability worsening by 40% compared with interferon beta 1a in relapsing-remitting multiple sclerosis. Studies have proven that Ocrevus therapy leads to fewer relapses than treatment with Rituximab, and it patients with Primary progressive multiple sclerosis (PPMS), Ocrevus has been proven to significantly lower the rate of progression into disability.
BCB Clinic in Bratislava is a clinic that offers specialized treatment for international neurological patients with chronic conditions, providing accessible high-quality medical care for individuals who can not afford top-of-the line care in their own countries for any reason.
BCB Clinic , in partnership with NHN Gate One Hotel, offers transportation to and from treatment sessions, specialized and individual care, and close support from a team of neurologists, nurses and customer satisfaction specialists. Our patients report a high rate of satisfaction and marked improvements in their condition after receiving appropriate care at our facility. Our mission statement is to provide the best possible care for patients from all over the world.
Thousands of people travel to Europe, Canada and Mexico in search of affordable, high-quality healthcare every year. BCB Clinic has extensive experience in welcoming, treating, and caring for international patients. We assist our patients with scheduling, finding accomodations, we arrange transportation and provide care.
If you wish to inquire about the possiblity of being treated with Ocrevus at our clinic, do not hesitate to contact us. We will provide you with all the information you need.
